Combination of Sorafenib With Standard Therapy in Newly Diagnosed Adult CBF AML
Clinical trial NCT05404516 · UNKNOWN
Trial details
- NCT number
- NCT05404516
- Sponsor
- Nanfang Hospital, Southern Medical University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-01-01
- Primary completion
- 2022-08-31
- Enrollment
- 88
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.